560 The Epigenetic Landscape of Moyamoya Disease
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
INTRODUCTION: Moyamoya Disease (MMD) is a rare progressive cerebrovascular illness that causes narrowing of blood vessels. Without early detection and treatment, MMD can cause strokes leading to life-long disabilities or death. Etiology is currently unknown, however; there seems to be a familial component. The goal of this study is to expand the on-going research on the genetic component of MMD. METHODS: We acquired single nucleotide polymorphisms (SNPs) from a genome-wide associated study done by Duan et al and Jeon et al. Histone peak files for human cell types of endothelial cells, macrophages, neutrophils, fibroblast, T-cells, B-cells, monocytes, natural killer cells and smooth muscle cells were downloaded from Cistrome. SNPs were mapped on linkage disequilibrium (LD) blocks using SniPA. In cell types with enriched histone marks, we used Juice Box to identify topological associated domains (TADs) and the genes within them. RESULTS: Fibroblast and Neutrophils showed significant enrichments within Moyamoya LD Blocks. Fourteen genes were found including RNF213 and TWIST1. RNF213 is known to play a role in angiogenesis and lipid metabolism while TWIST1 plays a role in downregulating the expression of inflammatory cytokines. CONCLUSIONS: Moyamoya associated SNPs have significant enrichments in Fibroblast and Neutrophil cell types. Based on these results, we suspect genetic risk for MMD to operate through fibroblast and neutrophils potentially influencing the expression genes affecting angiogenesis, inflammation and scaffold proteins.
Fields of Study & Subjects
Moyamoya disease diagnosis and treatment
Cerebrovascular and genetic disorders
Genomics and Rare Diseases
Publication details
- Journal / source
- Neurosurgery
- Volume
- 72
- Issue
- Supplement_1
- Pages
- 168–168
- Publication date
- 26 March 2026
- Language
- EN